๐Ÿ›๏ธ Verified NIH Record โ€ข Updated 2026-08-04

Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer (NCT01050504)

Molecular Correlates of Sensitivity and Resistance to Therapy in Genitourinary Malignancy

๐ŸŸข Recruiting Interventional Protocol ๐Ÿ“Š Observational Clinical Research Sponsor: University of Washington

๐Ÿฉบ Plain-English Summary (8th-Grade Level)

This study collects and studies tissue and blood samples from patients with prostate or bladder/urothelial cancer that has recurred (come back) at or near the same place as the original (primary) tumor or has spread to other parts of the body. Studying samples of blood and tissue samples from patients with prostate or bladder/urothelial cancer in the laboratory may help doctors learn more about new biomarkers, potential drug targets, and resistance developing in response to treatment. It may also help doctors find better ways to treat the cancer.

Who can join: Review the eligibility criteria below.

Location: Fred Hutch/University of Washington Cancer Consortium โ€” Seattle, Washington

Age range: 18 Years

๐Ÿงช Interventions in This Study

  • Cytology Specimen Collection Procedure (OTHER)
  • Laboratory Biomarker Analysis (OTHER)

๐Ÿ“‹ "Do I Qualify?" โ€” 1-Minute Self Screener

Instant Checklist

Full eligibility criteria are available on the official NIH protocol. View the criteria โ†—

๐Ÿ“ All Participating Trial Locations (1 Sites)

  • Fred Hutch/University of Washington Cancer Consortium โ€” Seattle, Washington

๐Ÿ“ž Contact the Study Coordinator

Phone: (206) 598-0856

Email: rbmontgo@uw.edu

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

๐Ÿ’ฐ Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Localized Renal Pelvis and Ureter Urothelial Carcinoma

๐Ÿ’ก How to Participate

  1. Check the checklist above to see if you may qualify.
  2. Contact the study coordinator using the phone/email above.
  3. Ask about the visit schedule, what is covered at no cost, and any travel support.
  4. Confirm with your own doctor before making a decision.
๐Ÿ›๏ธ View Official NIH Record โ†—